STANFORD UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-11-11

Employees: 10K

Market Cap: -

Website: http://www.stanford.edu

Clinical Trials

Perioperative Oral Steroids for Chronic Rhinosinusitis Without Polyps (CRSsNP)

Not Applicable

Completed

Conditions: Endoscopic Sinus Surgery
Oral Steroids
Chronic Rhinosinusitis Without Polyps
Chronic Rhinosinusitis

Interventions: Drug: Flonase
Drug: Prednisone

First Posted Date: 2016-04-22

Last Posted Date: 2020-08-04

Lead Sponsor: Stanford University

Target Recruit Count: 81

Registration Number: NCT02748070

Locations: 🇺🇸
Stanford University, Stanford, California, United States

Localized Therapeutics for the Treatment of Gastrointestinal Disorders II

Phase 1

Completed

Conditions: Colitis, Ulcerative

Interventions: Drug: Thermosensitive gel rectal formulation

First Posted Date: 2016-04-20

Last Posted Date: 2018-08-16

Lead Sponsor: Stanford University

Target Recruit Count: 3

Registration Number: NCT02745678

Locations: 🇺🇸
Stanford University, Stanford, California, United States

Food and the Brain

Completed

Conditions: Binge Eating

First Posted Date: 2016-04-19

Last Posted Date: 2020-10-20

Lead Sponsor: Stanford University

Target Recruit Count: 83

Registration Number: NCT02743000

Locations: 🇺🇸
Stanford University, Department of Psychiatry, Stanford, California, United States

Comparative Study of Menstrual Blood and Systemic Blood

Completed

Conditions: Retention; Menstruation

First Posted Date: 2016-04-15

Last Posted Date: 2022-12-05

Lead Sponsor: Stanford University

Target Recruit Count: 35

Registration Number: NCT02740816

Locations: 🇺🇸
Stanford University, Stanford, California, United States

Epidemiology of H. Pylori Transmission

Completed

Conditions: Communicable Diseases

First Posted Date: 2016-04-15

Last Posted Date: 2016-04-15

Lead Sponsor: Stanford University

Target Recruit Count: 1750

Registration Number: NCT02740140

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
🇺🇸
Santa Clara Public Health Clinics, San Jose, California, United States

Self-Administered Lidocaine Gel for Pain Management With IUD Insertion

Phase 3

Completed

Conditions: IUD Insertion

Interventions: Drug: Surgical Lubricant Jelly
Drug: Vaginal 2% Lidocaine

First Posted Date: 2016-04-14

Last Posted Date: 2019-06-06

Lead Sponsor: Stanford University

Target Recruit Count: 220

Registration Number: NCT02738203

Locations: 🇺🇸
Stanford Gynecology Clinic, Palo Alto, California, United States

Prospective Evaluation of a Surgical Solution for Breast Cancer-Associated Lymphedema

Not Applicable

Completed

Conditions: Edema
Lymphedema

Interventions: Device: Biobridge and lymph node transfer

First Posted Date: 2016-04-12

Last Posted Date: 2022-10-27

Lead Sponsor: Stanford University

Target Recruit Count: 1

Registration Number: NCT02734979

Locations: 🇺🇸
Stanford University, Stanford, California, United States

Simplified IUD Insertion Technique

Not Applicable

Withdrawn

Conditions: Contraception

Interventions: Procedure: Simplified IUD Insertion

First Posted Date: 2016-04-11

Last Posted Date: 2022-12-05

Lead Sponsor: Stanford University

Registration Number: NCT02733081

Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT

Phase 1

Terminated

Conditions: Adult Hodgkin Lymphoma
Adult Myelodysplastic Syndrome
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Childhood Hodgkin Lymphoma
Childhood Myelodysplastic Syndrome
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Myelofibrosis
Primary Myelofibrosis
Recurrent Adult Acute Lymphoblastic Leukemia

Interventions: Procedure: Allogeneic Hematopoietic Stem Cell Transplantation
Other: Laboratory Biomarker Analysis
Drug: Mycophenolate Mofetil
Drug: Sirolimus

First Posted Date: 2016-04-05

Last Posted Date: 2018-09-12

Lead Sponsor: Stanford University

Target Recruit Count: 1

Registration Number: NCT02728700

Locations: 🇺🇸
Stanford University, School of Medicine, Palo Alto, California, United States

Midostaurin in Treating Older Patients With Mutated Acute Myeloid Leukemia Post-Transplant

Phase 2

Withdrawn

Conditions: Acute Myeloid Leukemia With Gene Mutations
Adult Acute Myeloid Leukemia in Remission

Interventions: Drug: Midostaurin

First Posted Date: 2016-03-30

Last Posted Date: 2018-05-04

Lead Sponsor: Stanford University

Registration Number: NCT02723435

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy